The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Kari Laine

Department of Pharmacology and Clinical Pharmacology

University of Turku

Finland

[email]@utu.fi

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Pharmacology and Clinical Pharmacology, University of Turku, Finland. 1999 - 2004
  • Department of Medical Laboratory Sciences and Technology, Karolinska Institutet, Huddinge University Hospital, Sweden. 2000 - 2003

References

  1. Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics. Laine, K., De Bruyn, S., Björklund, H., Rouru, J., Hänninen, J., Scheinin, H., Anttila, M. Eur. J. Clin. Pharmacol. (2004) [Pubmed]
  2. Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy. Laine, K., Kytölä, J., Bertilsson, L. Ther. Drug. Monit (2004) [Pubmed]
  3. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Laine, K., Heikkinen, T., Ekblad, U., Kero, P. Arch. Gen. Psychiatry (2003) [Pubmed]
  4. A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes. Laine, K., Yasar, U., Widén, J., Tybring, G. Pharmacol. Toxicol. (2003) [Pubmed]
  5. Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone. Laine, K., Ahokoski, O., Huupponen, R., Hänninen, J., Palovaara, S., Ruuskanen, J., Björklund, H., Anttila, M., Rouru, J. Eur. J. Clin. Pharmacol. (2003) [Pubmed]
  6. CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline. Laine, K., Anttila, M., Nyman, L., Wahlberg, A., Bertilsson, L. Eur. J. Clin. Pharmacol. (2001) [Pubmed]
  7. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Laine, K., Tybring, G., Härtter, S., Andersson, K., Svensson, J.O., Widén, J., Bertilsson, L. Clin. Pharmacol. Ther. (2001) [Pubmed]
  8. No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects. Laine, K., Tybring, G., Bertilsson, L. Clin. Pharmacol. Ther. (2000) [Pubmed]
  9. Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy. Laine, K., Palovaara, S., Tapanainen, P., Manninen, P. Clin. Pharmacol. Ther. (1999) [Pubmed]
 
WikiGenes - Universities